Diversified conglomerate Fosun has made two new investments, participating in funding rounds for Israel-based medical device producer Check-Cap and China-based private courier service Beijing ZJS Express.
Beijing ZJS Express received an undisclosed amount from Fosun subsidiary Fosun Capital Group, Haitong Securities, China Merchants Securities, Hongtai Capital and Zhong Xinjian Merchants Equity Investment Fund, China Money Network reported on Friday.
ZJS is one of China’s leading express delivery services. The funds will help the company improve its management and expand its business.
Fosun Pharma, the conglomerate’s pharmaceutical subsidiary, participated in a $12m private placement of convertible notes for Check-Cap, the developer of a non-invasive preparation-free imaging test for colon cancer on Sunday.
The other investors in the placement were GE Healthcare, the healthcare subsidiary of industrial conglomerate General Electric, Docor, Pontifax, Counterpoint and MNS.
In 2012 Check-Cap raised an undisclosed amount from GE Healthcare and GE Capital through the corporate’s Healthymagination fund. It also raised $9.8m in 2011 from four undisclosed investors.